Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,951 Cr
down ₹247 Cr vs Jan 2025
- Stocks held
- 31
- unchanged
- Top 10 weight
- 63.4%
- of the portfolio in its ten largest
- Cash & debt
- 1.7%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 7, trimmed 25
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In February 2025 it disclosed 31 stocks worth ₹2,951 Cr, down ₹247 Cr from Jan 2025. Its largest positions were Suven Pharmaceuticals Limited (10.2%), Sun Pharmaceutical Industries Limited (10.1%), Cipla Limited (8.5%); the ten largest together made up 63.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 65.2% of its equity. Cash and debt stood at 1.7%. Compared with Jan 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
27%
Holds more cash than 27% of peers
Holdings in February 2025
Download CSVEvery line the fund disclosed, with the change against Jan 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 10.25%
- Δ weight
- up 2.04 pts
- Value
- ₹302 Cr
- Δ value
- up ₹39.8 Cr
- Status
- Added
- Weight
- 10.13%
- Δ weight
- down 0.10 pts
- Value
- ₹299 Cr
- Δ value
- down ₹28.3 Cr
- Status
- Trimmed
- Weight
- 8.54%
- Δ weight
- up 0.26 pts
- Value
- ₹252 Cr
- Δ value
- down ₹12.9 Cr
- Status
- Trimmed
- Weight
- 7.37%
- Δ weight
- up 0.13 pts
- Value
- ₹217 Cr
- Δ value
- down ₹14.1 Cr
- Status
- Trimmed
- Weight
- 6.39%
- Δ weight
- down 0.36 pts
- Value
- ₹189 Cr
- Δ value
- down ₹27.2 Cr
- Status
- Trimmed
- Weight
- 4.84%
- Δ weight
- up 0.45 pts
- Value
- ₹143 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 4.22%
- Δ weight
- down 1.55 pts
- Value
- ₹124 Cr
- Δ value
- down ₹60.1 Cr
- Status
- Trimmed
- Weight
- 4.00%
- Δ weight
- down 0.15 pts
- Value
- ₹118 Cr
- Δ value
- down ₹14.8 Cr
- Status
- Trimmed
- Weight
- 3.96%
- Δ weight
- down 0.16 pts
- Value
- ₹117 Cr
- Δ value
- down ₹14.8 Cr
- Status
- Trimmed
- Weight
- 3.73%
- Δ weight
- up 0.45 pts
- Value
- ₹110 Cr
- Δ value
- up ₹5.3 Cr
- Status
- Added
- Weight
- 3.59%
- Δ weight
- down 0.51 pts
- Value
- ₹106 Cr
- Δ value
- down ₹25.1 Cr
- Status
- Trimmed
- Weight
- 3.19%
- Δ weight
- up 0.28 pts
- Value
- ₹94 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Weight
- 3.16%
- Δ weight
- down 0.14 pts
- Value
- ₹93.3 Cr
- Δ value
- down ₹12.1 Cr
- Status
- Trimmed
- Weight
- 3.01%
- Δ weight
- up 0.18 pts
- Value
- ₹88.8 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 2.75%
- Δ weight
- down 0.07 pts
- Value
- ₹81.3 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Weight
- 2.71%
- Δ weight
- up 0.04 pts
- Value
- ₹79.9 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 2.48%
- Δ weight
- down 1.45 pts
- Value
- ₹73.3 Cr
- Δ value
- down ₹52.5 Cr
- Status
- Trimmed
- Weight
- 2.15%
- Δ weight
- down 0.37 pts
- Value
- ₹63.5 Cr
- Δ value
- down ₹17.3 Cr
- Status
- Trimmed
- Weight
- 1.73%
- Δ weight
- up 0.10 pts
- Value
- ₹51 Cr
- Δ value
- down ₹94 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.73%
- Δ weight
- up 0.93 pts
- Value
- ₹51 Cr
- Δ value
- up ₹25.6 Cr
- Status
- Added
- Weight
- 1.57%
- Δ weight
- up 0.18 pts
- Value
- ₹46.4 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 1.38%
- Δ weight
- down 0.02 pts
- Value
- ₹40.8 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 1.29%
- Δ weight
- up 0.20 pts
- Value
- ₹38.1 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 1.14%
- Δ weight
- down 0.18 pts
- Value
- ₹33.7 Cr
- Δ value
- down ₹8.5 Cr
- Status
- Trimmed
- Weight
- 1.01%
- Δ weight
- down 0.05 pts
- Value
- ₹29.9 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.67%
- Δ weight
- down 0.01 pts
- Value
- ₹19.8 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 0.59%
- Δ weight
- down <0.01 pts
- Value
- ₹17.3 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 0.53%
- Δ weight
- down 0.04 pts
- Value
- ₹15.7 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 0.52%
- Δ weight
- down <0.01 pts
- Value
- ₹15.3 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- down 0.02 pts
- Value
- ₹13.9 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- up 0.03 pts
- Value
- ₹13.7 Cr
- Δ value
- down ₹17 L
- Status
- Trimmed
- Weight
- 0.32%
- Δ weight
- down 0.11 pts
- Value
- ₹9.5 Cr
- Δ value
- down ₹4.3 Cr
- Status
- Trimmed
- Weight
- 0.10%
- Δ weight
- up 0.03 pts
- Value
- ₹2.9 Cr
- Δ value
- up ₹65 L
- Status
- Added
What changed, Jan 2025 to Feb 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹39.8 Cr (+2.04% pts)
- Sai Life Sciences Limitedup ₹5.3 Cr (+0.45% pts)
- Abbott Laboratoriesup ₹3.1 Cr (+0.20% pts)
- Gland Pharma Limitedup ₹2.6 Cr (+0.45% pts)
- Narayana Hrudayalaya Limitedup ₹1.8 Cr (+0.18% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2025, the weight rose most in Pharmaceuticals & Biotechnology (+1.5 pts), and fell most in Healthcare Services (−1.4 pts).
- Pharmaceuticals & Biotechnology63.7% → 65.2%+1.5 pts
- Healthcare Services18.9% → 17.5%−1.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2022 | Feb 2024 | Aug 2024 | Nov 2024 | Jan 2025 | Feb 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 53.6% | 70.8% | 67.9% | 64.2% | 63.7% | 65.2% |
| Healthcare Services | 29.0% | 14.0% | 15.9% | 18.3% | 18.9% | 17.5% |
| Healthcare Equipment & Supplies | 6.2% | 7.1% | 8.3% | 9.1% | 10.2% | 10.1% |
| Pharmaceuticals | 7.2% | 5.7% | 5.6% | 6.4% | 5.3% | 5.3% |
| Insurance | 2.5% | 1.8% | 1.9% | 1.5% | 1.4% | 1.4% |
| Retailing | 1.6% | 0.6% | 0.5% | 0.5% | 0.4% | 0.5% |
Allocation in Feb 2025change vs Jan 2025
- Pharmaceuticals & Biotechnology (15)65.2%▲ 1.5 pts
- Healthcare Services (8)17.5%▼ 1.4 pts
- Healthcare Equipment & Supplies (3)10.1%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Feb 2025
1.7%
▲ 0.9 pts vs Jan 2025
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- 1.9%
- Feb 2024 · now ▼ 0.1 pts
- Last 12 months
- 0.8% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.